COVID-19 induces a robust, extended inflammatory “cytokine storm” that contributes to an increased morbidity and mortality, particularly in patients with type 2 diabetes (T2D). Macrophages are a key innate immune cell population responsible for the cytokine storm that has been shown, in T2D, to promote excess inflammation in response to infection. Using peripheral monocytes and… Continue reading #Coronavirus induces #diabetic macrophage-mediated inflammation via SETDB2
Tag: coronavirus
#Probenecid inhibits #SARS-CoV-2 replication in vivo and in vitro
Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19. We show probenecid potently blocks SARS-CoV-2 replication in mammalian cells and virus replication in a hamster model. Furthermore, we demonstrate… Continue reading #Probenecid inhibits #SARS-CoV-2 replication in vivo and in vitro
#Metoprolol in Critically Ill Patients With COVID-19
Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils. The beta-blocker metoprolol has been shown to ameliorate exacerbated inflammation in the myocardial infarction setting. ObjectivesThe purpose of this study was to evaluate the effects of metoprolol on alveolar inflammation and on respiratory function in… Continue reading #Metoprolol in Critically Ill Patients With COVID-19
#Ivermectin for Prevention and Treatment of #COVID-19Infection: A Systematic Review, Meta-analysis, and TrialSequential Analysis to Inform Clinical Guidelines
Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasiticivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Areas of uncertainty: We assessed the efficacy of ivermectin treatment in reducing mortality, in secondary outcomes, and in chemoprophylaxis, among people with, or at high risk of, COVID-19 infection.… Continue reading #Ivermectin for Prevention and Treatment of #COVID-19Infection: A Systematic Review, Meta-analysis, and TrialSequential Analysis to Inform Clinical Guidelines
#COVID-19 Transmission Dynamics Among Close #Contacts of Index Patients With COVID-19A Population-Based Cohort Study in Zhejiang Province, China
Much remains unknown about the transmission dynamics of COVID-19. How the severity of the index case and timing of exposure is associated with disease in close contacts of index patients with COVID-19 and clinical presentation in those developing disease is not well elucidated. Objectives To investigate the association between the timing of exposure and development… Continue reading #COVID-19 Transmission Dynamics Among Close #Contacts of Index Patients With COVID-19A Population-Based Cohort Study in Zhejiang Province, China
Limited protection against #SARS-CoV-2 infection and virus transmission after mRNA #vaccination
Stang and coworkers have recently reported in the Journal that “RT-PCR test results as gold standard for assessing and controlling infectiousness fail”[1]. The authors analyzed two scenarios and used Ct25 and Ct30 as thresholds for infectiousness and conclude that more than the half of their patient cohort was unlikely to have been infectious, i.e. the… Continue reading Limited protection against #SARS-CoV-2 infection and virus transmission after mRNA #vaccination
Association of poor #housing conditions with #COVID-19 incidence and mortality across US counties
Poor housing conditions have been linked with worse health outcomes and infectious disease spread. Since the relationship of poor housing conditions with incidence and mortality of COVID-19 is unknown, we investigated the association between poor housing condition and COVID-19 incidence and mortality in US counties. MethodsWe conducted cross-sectional analysis of county-level data from the US… Continue reading Association of poor #housing conditions with #COVID-19 incidence and mortality across US counties
First #monoclonal antibody treatment for #COVID-19 approved for use in the UK
Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government’s independent expert scientific advisory body, the MHRA has approved Ronapreve as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection for… Continue reading First #monoclonal antibody treatment for #COVID-19 approved for use in the UK
Early detection of #COVID-19 in the UK using self-reported #symptoms: a large-scale, prospective, epidemiological surveillance study
.. The early detection of COVID-19 is helpful for resource allocation during the pandemic. Here, we have proposed a Bayesian approach to identify individuals with probable COVID-19 on the basis of self-reported symptoms during 1, 2, and 3 days after symptom onset and demographic information. Using a unique, prospective dataset, we evaluated the proposed method… Continue reading Early detection of #COVID-19 in the UK using self-reported #symptoms: a large-scale, prospective, epidemiological surveillance study
2 Medical News 